Dean O Campbell

Dean O Campbell

Company: Crown BioScience, Inc.

Job title: Director Scientific Engagement Oncology-West

Seminars:

Panel Discussion: Taking a Step Back – How Can the Preclinical Oncology Field Work Together to Improve the Success Rate of IO Therapeutics? 12:00 pm

Steering the candidates with the most potential to the clinic is a difficult task, but one that in the end benefits patients and industry alike. Advancing the field onwards is a task will require collaboration between academia and industry; in vivo and in vitro teams alike. In this panel we’ll discuss where the main ‘sticking…Read more

day: Day One

Patient-Derived Experimental Models for Translational Cancer Research 11:30 am

• Patient-derived organoids (PDO) and Patient-derived xenografts (PDX) are patient-relevant platforms for efficacy evaluation of cancer therapeutics • PDX-derived organoids (PDXO) is a new in vitro platform featuring both patient relevance and scalability • Leveraging our extensive PDX collection to run surrogate clinical trials in a preclinical settingRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.